30 April 2022 in Journal of Yeungnam Medical Science
Vertigo is the sensation of self-motion of the head or body when no self-motion is occurring or the sensation of distorted self-motion during an otherwise normal head movement. Representative peripheral vertigo disorders include benign paroxysmal positional vertigo, Ménière disease, and vestibular neuritis. Vestibular neuritis, also known as vestibular neuronitis, is the third most common peripheral vestibular disorder after benign paroxysmal positional vertigo and Ménière disease. The cause of vestibular neuritis remains unclear. However, a viral infection of the vestibular nerve or ischemia of the anterior vestibular artery is known to cause vestibular neuritis. In addition, recent studies on immune-mediated mechanisms as the cause of vestibular neuritis have been reported. The characteristic clinical features of vestibular neuritis are abrupt true-whirling vertigo lasting for more than 24 hours, and no presence of cochlear symptoms and other neurological symptoms and signs. To accurately diagnose vestibular neuritis, various diagnostic tests such as the head impulse test, bithermal caloric test, and vestibular-evoked myogenic potential test are conducted. Various treatments for vestibular neuritis have been reported, which are largely divided into symptomatic therapy, specific drug therapy, and vestibular rehabilitation therapy. Symptomatic therapies include generalized supportive care and administration of vestibular suppressants and antiemetics. Specific drug therapies include steroid therapy, antiviral therapy, and vasodilator therapy. Vestibular rehabilitation therapies include generalized vestibular and customized vestibular exercises.
1 August 2021 in Clinical and Experimental Otorhinolaryngology
Objectives. The emergence of electronic cigarettes (e-cigarettes) has created new perceptions of the tobacco market. Unlike traditional tobacco, the greatest advantage of e-cigarettes is that they have less smell and are convenient and inexpensive. Most e-cigarette smokers believe that e-cigarette smoking is less harmful than traditional smoking. Information on the effects of e-cigarettes on human health is limited, and the issue remains controversial.Methods. We studied the effects of e-cigarette vapor on mucin (MUC5AC and MUC5B) and the change of MUC5AC and MUC5B from e-cigarette liquid with or without nicotine in respiratory epithelial cells. The effects of e-cigarette vapor with or without nicotine on mucin, along with the involved signaling pathways, were investigated using reverse transcriptase-polymerase chain reaction (PCR), real-time PCR, enzyme immunoassays, and immunoblot analysis with several specific inhibitors and small interfering RNA.Results. E-cigarette vapor with or without nicotine stimulated MUC5AC, but not MUC5B, expression in respiratory epithelial cells. In addition, we showed that e-cigarette vapor with and without nicotine induced MUC5AC expression via activation of the mitogen-activated protein kinase (MAPK; extracellular signal-regulated kinase [ERK] 1/2 and p38) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways in human airway epithelial cells.Conclusion. E-cigarette vapor with and with nicotine significantly increased MUC5AC expression in human airway epithelial cells.
26 August 2020 in International Forum of Allergy & Rhinology
1 January 2022 in BioMed Research International
Background. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes a novel infectious respiratory disease called COVID‐19, which is threatening public health worldwide. SARS‐CoV‐2 spike proteins connect to the angiotensin converting enzyme 2 (ACE2) receptor through the receptor binding domain and are then activated by the transmembrane protease serine subtype 2 (TMPRSS2). The ACE2 receptor is highly expressed in human nasal epithelial cells. Nasal ciliated cells are primary targets for SARS‐CoV‐2 replication. However, the effect of SARS‐CoV‐2 on the upper respiratory tract remains unknown, thus leading to the purpose of our study. We investigate the effects of SARS‐CoV‐2 on cytokines and mucin expression in human nasal epithelial cells. Methods. We investigated the effects of the SARS‐CoV‐2 spike protein receptor binding domain (RBD) on cytokines (IL‐1β, IL‐6, and IL‐8) and MUC5AC/5B expression via real‐time PCR, ELISA, periodic acid‐Schiff (PAS) staining, and immunofluorescence staining in cultured human nasal epithelial cells. Results. The mRNA expression and protein production of cytokines (IL‐1β, IL‐6, and IL‐8) and MUC5AC/5B were increased by SARS‐CoV‐2 spike protein RBD. ACE2 receptor inhibitor suppressed the expression of cytokines (IL‐1β, IL‐6, and IL‐8) and MUC5AC/5B induced by SARS‐CoV‐2 spike protein RBD. Conclusions. SARS‐CoV‐2 induced cytokines (IL‐1β, IL‐6, and IL‐8) and MUC5AC/5B expression through the ACE 2 receptor in human nasal epithelial cells. Therefore, ACE2 receptor inhibitors can be an effective therapeutic option for SARS‐CoV‐2 infection.
28 February 2023 in Clinical and Experimental Otorhinolaryngology
Objectives. Obesity, which induces chronic low-grade systemic inflammation in the human body, is a known risk factor for various diseases. Recent studies have shown associations between various otorhinolaryngological diseases and obesity. In particular, inflammatory sinonasal diseases have been found to be strongly associated with obesity-related proinflammatory mediators. Many studies have been conducted to identify therapeutic agents for controlling obesity-related inflammatory airway diseases. Ghrelin, an endogenous peptide from the stomach, has anti-inflammatory and antioxidative effects in a wide range of tissues. However, the effect of ghrelin on the regulation of mucus secretion has not yet been studied in the human nasal mucosa. Therefore, we investigated the effects of ghrelin on lipopolysaccharide (LPS)/leptin-mediated MUC5AC expression and mechanisms involved in human nasal epithelial cells (HNEpCs).Methods. In HNEpCs, the effect and signaling pathways of ghrelin on LPS/leptin-induced MUC5AC expression were examined using reverse transcription polymerase chain reaction, real-time polymerase chain reaction, enzyme immunoassays, Western blotting, and immunofluorescence staining.Results. Growth hormone secretagogue receptor 1a (GHSR1a) was expressed in the HNEpCs. Ghrelin downregulated LPS/leptin-induced MUC5AC expression, which was abolished by D-Lys-3-growth hormone-releasing peptide 6 (D-Lys-3-GHRP-6). Ghrelin significantly inhibited LPS/leptin-activated extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinases (MAPKs). These ghrelin-mediated changes in MAPK activation were abolished by D-Lys-3-GHRP-6. These results showed that ghrelin inhibits LPS/leptin-induced MUC5AC overexpression by modulating the ERK1/2 and p38 MAPK pathways in HNEpCs.Conclusion. These findings suggest that ghrelin is a potential therapeutic agent for treating obesity-related inflammatory sinonasal diseases.
25 August 2021 in The Turkish Journal of Pediatrics
Background. Ectopic eruption of supernumerary teeth in the nasal cavity is extremely rare, and most cases usually involve the maxillary sinus or are accompanied by dental cysts. It is usually discovered during adulthood. Case. A 5-year-old patient presented with an intranasal mass and intermittent nasal bleeding that lasted for 1 year. He was taking medication for symptoms of allergic rhinitis, such as nasal obstruction and intermittent epistaxis, without any endoscopic evaluation for 1 year. On nasal endoscopy, a needlelike whitish mass was observed on the left nasal floor. On paranasal sinus computed tomography, it appeared as a pointed highdensity mass covered by soft tissue. The intranasal mass which was a supernumerary tooth was completely removed using a pediatric endoscope. Conclusions. Detection of supernumerary teeth in the nasal cavity of children without symptoms is difficult, and it can be delayed; although the child, in this case, had nonspecific nasal symptoms, supernumerary teeth was not considered in the diagnosis. This case report raises awareness and provides evidence for the clinical characterization and optimal treatment of supernumerary teeth in children.